BlackRock, Inc. 13D and 13G filings for CymaBay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-25 1:48 pm Purchase |
2023-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
BlackRock Inc. BLK |
9,610,239 8.500% |
7,662,206 (+393.33%) |
Filing |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | CymaBay Therapeutics, Inc. CBAY |
BlackRock Inc. BLK |
1,948,033 2.300% |
-3,376,095 (-63.41%) |
Filing |
| 2022-02-01 5:08 pm Sale |
2021-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
BlackRock Inc. BLK |
5,324,128 6.300% |
-62,116 (-1.15%) |
Filing |
| 2021-01-29 09:57 am Sale |
2020-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
BlackRock Inc. BLK |
5,386,244 7.800% |
-203,607 (-3.64%) |
Filing |